SOW
CRL icon

State of Wyoming’s Charles River Laboratories CRL Stock Holding History

State of Wyoming’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
1,196
-207
-15% -$36.9K 0.03% 763
2026
Q1 		$242K Sell
1,403
-2,203
-61% -$408K 0.03% 818
2025
Q4 		$719K Buy
3,606
+1,357
+60% +$246K 0.08% 194
2025
Q3 		$352K Buy
2,249
+287
+15% +$45.6K 0.04% 587
2025
Q2 		$298K Buy
1,962
+494
+34% +$65.9K 0.04% 655
2025
Q1 		$221K Buy
1,468
+208
+17% +$34.9K 0.03% 745
2024
Q4 		$233K Buy
1,260
+167
+15% +$32.2K 0.03% 734
2024
Q3 		$215K Buy
1,093
+144
+15% +$29.9K 0.03% 658
2024
Q2 		$196K Buy
949
+52
+6% +$11.8K 0.03% 570
2024
Q1 		$243K Buy
897
+186
+26% +$44.4K 0.04% 474
2023
Q4 		$168K Buy
711
+103
+17% +$20.3K 0.03% 676
2023
Q3 		$119K Buy
608
+196
+48% +$40.2K 0.03% 760
2023
Q2 		$86.6K Buy
412
+104
+34% +$20.7K 0.03% 909
2023
Q1 		$62.2K Buy
308
+3
+1% +$680 0.02% 1017
2022
Q4 		$66.5K Sell
305
-25
-8% -$5.46K 0.02% 949
2022
Q3 		$65K Buy
330
+13
+4% +$2.81K 0.03% 876
2022
Q2 		$68K Sell
317
-57
-15% -$13.9K 0.04% 745
2022
Q1 		$106K Sell
374
-88
-19% -$27.1K 0.05% 549
2021
Q4 		$174K Sell
462
-198
-30% -$76.9K 0.08% 283
2021
Q3 		$273K Sell
660
-95
-13% -$39.5K 0.18% 97
2021
Q2 		$279K Buy
755
+747
+9,338% +$249K 0.18% 104
2021
Q1 		$2K Buy
+8
New +$2.22K ﹤0.01% 469

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

State of Wyoming's CRL Position: Q2 2026 in Review

State of Wyoming reduced its Charles River Laboratories (CRL) stake by 15% in Q2 2026, selling an estimated $36.9K and leaving 1,196 shares worth $271K. The position accounts for 0.03% of the portfolio, ranked #763.

State of Wyoming first reported a position in CRL in Q1 2021 and has held it in 22 quarters since. The position peaked at $719K in Q4 2025. 260 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • State of Wyoming held 1,196 shares of Charles River Laboratories worth $271K as of Q2 2026.
  • State of Wyoming sold 207 Charles River Laboratories shares in Q2 2026, an estimated $36.9K.
  • Charles River Laboratories made up 0.03% of State of Wyoming's portfolio in Q2 2026, its #763 holding.
  • State of Wyoming first reported a position in Charles River Laboratories in Q1 2021 and has held it in 22 quarters since.
  • State of Wyoming's Charles River Laboratories position peaked at $719K in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.